 Inari Medical Inc NASDAQ: NARI expects Q4 FY21 sales of 82.8 million - 83.3 million, up 14 sequentially and 71 year-over-year at the midpoint of the range, beating the consensus of 73.16 million. For FY21, the company sees revenue of 276.6 million - 277.1 million, up approximately 98 YY, well ahead of the consensus of 267.12 million and prior guidance of 266 million - 268 million. 